sar
coronaviru
sarscov
administ
intranas
intratrach
rhesu
cynomolgu
african
green
monkey
agm
replic
respiratori
tract
induc
ill
titer
serum
neutral
antibodi
correl
level
viru
replic
respiratori
tract
agmncynomolgusnrhesu
moder
high
titer
sarscov
associ
interstiti
pneumon
detect
lung
agm
day
resolv
day
postinfect
follow
challeng
agm
month
later
viru
replic
highli
restrict
evid
enhanc
diseas
speci
use
evalu
immunogen
candid
vaccin
lack
appar
clinic
ill
three
speci
variabl
anim
anim
level
viral
replic
rapid
clearanc
viru
pneumon
agm
must
taken
account
investig
consid
use
speci
efficaci
challeng
studi
publish
elsevi
inc
sever
acut
respiratori
syndrom
sar
recogn
late
end
outbreak
juli
case
death
attribut
sar
worldwid
new
coronaviru
term
sar
coronaviru
sarscov
isol
patient
sar
ksiazek
et
al
poutanen
et
al
soon
diseas
recogn
abil
experiment
infect
induc
interstiti
pneumon
cynomolgu
macaqu
sarscov
demonstr
thu
fulfil
koch
postul
confirm
sarscov
caus
agent
sar
kuiken
et
al
effort
develop
anim
diseas
model
sar
continu
balbc
mice
establish
good
rodent
model
replic
sarscov
viral
replic
also
demonstr
ferret
cat
martina
et
al
although
pig
chicken
could
experiment
infect
sarscov
speci
support
effici
viru
replic
weingartl
et
al
addit
import
establish
microbi
etiolog
diseas
anim
model
critic
studi
diseas
pathogenesi
evalu
treatment
control
strategi
nonhuman
primat
use
evalu
vaccin
studi
diseas
pathogenesi
sever
respiratori
virus
includ
influenza
respiratori
syncyti
viru
human
parainfluenza
virus
crow
et
al
durbin
et
al
murphi
et
al
rimmelzwaan
et
al
skiadopoulo
et
al
studi
demonstr
suscept
differ
monkey
speci
specif
respiratori
virus
variabl
howev
assess
level
viru
replic
respiratori
tract
model
inform
primari
purpos
studi
identifi
permiss
nonhuman
primat
speci
could
serv
reproduc
inform
model
evalu
sar
vaccin
immunotherapi
evalu
level
viru
replic
serolog
respons
infect
sarscov
three
speci
old
world
monkey
first
undertook
comparison
level
replic
sarscov
administ
via
respiratori
rout
three
speci
old
world
monkey
african
green
rhesu
cynomolgu
monkey
clinic
sign
febril
respiratori
ill
defin
sar
human
afebril
respiratori
tract
ill
observ
monkey
follow
administr
tissu
cultur
infecti
dose
tcid
sar
cov
rectal
temperatur
monkey
remain
normal
rang
durat
studi
except
one
african
green
monkey
agm
fever
day
level
replic
sarscov
upper
lower
respiratori
tract
monkey
three
speci
detect
combin
nose
throat
nt
swab
tracheal
lavag
tl
sampl
present
fig
level
viral
replic
agm
greater
cynomolgu
monkey
greater
rhesu
monkey
mean
peak
viru
titer
agm
tcid
ml
upper
lower
respiratori
tract
respect
panel
e
f
plasma
urin
fecal
specimen
rhesu
monkey
agm
yield
infecti
viru
viral
genom
detect
reversetranscriptas
polymeras
chain
reaction
rtpcr
fecal
sampl
four
sarsinfect
agm
day
data
shown
laboratori
evalu
agm
reveal
two
find
observ
rhesu
cynomolgu
monkey
suggest
system
infect
may
warrant
investig
first
hemoglobin
concentr
hematocrit
four
agm
decreas
mean
day
follow
infect
return
baselin
day
total
white
blood
cell
platelet
count
demonstr
similar
pattern
second
liver
enzym
elev
alanin
amino
transferas
isocitr
dehydrogenas
note
serum
two
agm
peak
level
day
postinfect
valu
return
baselin
day
serum
igg
antibodi
titer
recombin
baculovirusexpress
spike
protein
sarscov
measur
elisa
assay
tabl
fourfold
rise
titer
detect
monkey
follow
primari
infect
titer
preinfect
day
sera
rang
suggest
although
elisa
assay
detect
fourfold
rise
follow
infect
also
detect
preexist
crossreact
antibodi
monkey
seroneg
titer
b
sarsspecif
neutral
antibodi
nt
ab
prior
viru
administr
tabl
mean
titer
nt
ab
achiev
day
three
speci
monkey
correl
level
viru
replic
respiratori
tract
mean
titer
rhesu
monkey
cynomolgu
monkey
african
green
monkey
tabl
assay
mean
neutral
antibodi
titer
postinfect
sera
mice
titer
convalesc
human
serum
sampl
unpublish
data
serolog
evid
infect
defin
fourfold
rise
nt
ab
titer
observ
rhesu
cynomolgu
agm
although
studi
describ
indic
three
speci
monkey
infect
sarscov
signific
discrep
find
publish
report
cynomolgu
macaqu
infect
sarscov
kuiken
et
al
report
clinic
ill
patholog
evid
diseas
cynomolgu
macaqu
euthan
monkey
first
studi
unabl
determin
whether
histolog
chang
associ
viru
replic
order
resolv
differ
perform
addit
studi
six
agm
four
agm
receiv
dose
tcid
sarscov
intranas
intratrach
administr
two
mockinfect
two
infect
mockinfect
anim
euthan
necropsi
day
remain
two
infect
one
mockinfect
anim
euthan
necropsi
day
combin
nt
swab
collect
daili
tl
fluid
collect
everi
day
till
anim
euthan
could
determin
accur
nt
swab
tl
sampl
reflect
level
viru
replic
lung
necropsi
trachea
nasal
turbin
sampl
anim
lung
assay
viru
titrat
histopatholog
sampl
liver
spleen
examin
histopatholog
chang
three
four
sarscovinfect
agm
viru
titer
tl
sampl
accur
reflect
titer
viru
present
tracheal
lung
tissu
tabl
consist
higher
titer
viru
seen
lung
tracheal
nasal
turbin
tissu
homogen
nt
swab
tl
sampl
tabl
moder
agm
id
high
agm
id
titer
viru
present
tissu
sampl
right
lung
day
detect
viru
patchi
titer
significantli
lower
day
tabl
viru
titer
sampl
right
lung
higher
sampl
left
lung
presum
right
main
stem
bronchu
straighter
intratrach
administ
viru
inoculum
reach
right
lung
differ
titer
viru
sampl
collect
hilar
region
compar
peripheri
lung
data
shown
microscop
examin
lung
agm
sacrif
day
postinfect
reveal
focal
interstiti
mononuclear
inflammatori
infiltr
fig
edema
lung
immunohistochem
assay
ihc
show
focal
distribut
viral
antigen
tracheal
bronchiolar
epitheli
cell
pneumocyt
fig
macrophag
day
postinfect
ihc
doubl
stain
confirm
major
sarscovantigenposit
cell
type
pneumocyt
colabel
cytokeratin
colabel
surfact
fig
scatter
macrophag
colabel
antibodi
fig
degre
inflamm
amount
viral
antigen
significantli
reduc
lung
anim
fig
sarscov
replic
respiratori
tract
monkey
mean
titer
viru
express
log
tcid
ml
sampl
axi
detect
indic
day
x
axi
upper
respiratori
tract
left
panel
c
e
close
symbol
lower
respiratori
tract
right
panel
b
f
open
symbol
rhesu
panel
b
x
w
cynomolgu
panel
c
e
african
green
panel
e
f
n
monkey
follow
intranas
intratrach
administr
tcid
sarscov
error
bar
associ
data
point
indic
standard
error
dot
line
indic
lower
limit
detect
viru
tcid
ml
sacrif
day
postinfect
compar
find
day
postinfect
data
shown
promin
histopatholog
chang
immunostain
observ
liver
spleen
day
day
postinfect
abil
primari
infect
prevent
reinfect
evalu
agm
four
agm
first
studi
challeng
dose
tcid
sarscov
administ
via
intratrach
intranas
rout
month
follow
primari
infect
studi
perform
establish
viru
titer
tissu
homogen
exceed
titer
seen
respiratori
secret
nt
swab
tl
collect
anim
follow
challeng
viru
replic
highli
restrict
respiratori
tract
upon
challeng
viru
isol
upper
respiratori
tract
monkey
isol
singl
time
point
day
lowest
detect
titer
lower
respiratori
tract
agm
id
possibl
low
titer
repres
residu
viru
inoculum
rule
agm
measur
nt
ab
present
prior
challeng
two
agm
id
develop
fourfold
rise
titer
data
shown
suggest
although
viru
replic
restrict
respiratori
tract
upon
challeng
least
two
monkey
reinfect
compar
respons
three
speci
old
world
monkey
experiment
infect
sarscov
establish
although
clinic
ill
present
three
speci
rhesu
agm
one
cynomolgu
monkey
could
infect
sarscov
replic
higher
titer
longer
time
respiratori
tract
agm
rhesu
cynomolgu
monkey
nt
ab
respons
correl
level
viru
replic
detect
respiratori
tract
consist
higher
titer
viru
seen
tissu
homogen
necropsi
nt
swab
tl
fluid
collect
anim
sacrif
indic
viru
present
tissu
secret
observ
consist
clinic
find
sever
lung
diseas
occur
earli
sar
case
time
viru
easili
detect
respiratori
secret
histopatholog
examin
agm
lung
reveal
interstiti
pneumon
associ
sarscov
day
resolv
day
ihc
stain
sarscov
antigen
doubl
stain
show
tracheal
bronchial
epitheli
cell
type
pneumocyt
involv
earli
infect
find
consist
find
mice
hamster
infect
sarscov
antigen
detect
epitheli
cell
earli
infect
robert
et
al
press
subbarao
et
al
monkey
receiv
ml
tcid
sarscov
intranas
intratrach
administr
day
sera
collect
viru
administr
day
later
b
sera
test
start
dilut
serum
sampl
neutral
viru
infect
start
dilut
assign
titer
determin
fourfold
rise
c
fourfold
rise
titer
indic
bold
type
four
agm
receiv
tcid
sarscov
intranas
intratrach
administr
day
b
viru
titer
express
log
tcid
ml
secret
log
tcid
g
wv
tissu
homogen
c
titer
lung
express
mean
f
standard
error
sampl
obtain
lobe
lung
viru
detect
lower
limit
detect
tissu
homogen
tcid
g
nt
swab
tl
tcid
ml
find
consist
report
kuiken
et
al
haagman
et
al
appear
patchi
though
see
evid
pneumon
earlier
time
point
postinfect
report
haagman
et
al
day
instead
day
respect
kuiken
et
al
also
found
one
four
macaqu
detect
viru
lung
day
key
differ
remain
unresolv
find
kuiken
et
al
observ
lethargi
skin
rash
respiratori
distress
cynomolgu
macaqu
rhesu
agm
infect
urbani
strain
sarscov
kuiken
et
al
infect
cynomolgu
monkey
administr
hong
kong
sarscov
strain
nose
trachea
conjunctiva
studi
done
urbani
strain
administ
nose
trachea
possibl
reason
could
account
differ
find
report
kuiken
et
al
cynomolgu
monkey
differ
strain
sarscov
use
differ
subspeci
monkey
two
studi
strain
sarscov
isol
fatal
human
case
subsequ
underw
similar
number
passag
vero
cell
howev
possibl
strain
use
studi
kuiken
et
al
virul
cynomolgu
monkey
question
resolv
evalu
strain
parallel
concern
risk
enhanc
diseas
reexposur
sar
describ
felin
infecti
periton
viru
infect
fipv
cat
acceler
enhanc
diseas
occur
reexposur
fipv
seroposit
cat
pederson
boyl
scott
infect
macrophag
fipv
believ
import
pathogenesi
acceler
diseas
sarscov
primarili
infect
epitheli
cell
lung
agm
evid
infect
macrophag
well
warrant
studi
howev
lack
clinic
ill
activ
viral
replic
challeng
agm
reassur
follow
agm
month
challeng
saw
evid
enhanc
diseas
evid
viru
replic
lung
liver
kidney
spleen
intestin
necropsi
month
follow
challeng
observ
consist
find
mice
hamster
primari
infect
sarscov
confer
resist
reinfect
detect
evid
enhanc
diseas
upon
reexposur
sarscov
robert
et
al
press
subbarao
et
al
care
consid
optim
use
three
nonhuman
primat
speci
context
avail
anim
model
sar
includ
mice
hamster
ferret
serolog
data
studi
confirm
nonhuman
primat
use
vaccin
immunogen
studi
gao
et
al
virolog
data
histopatholog
find
indic
agm
use
vaccin
efficaci
studi
bukreyev
et
al
sarscov
titer
lung
tissu
homogen
high
one
agm
moder
high
day
significantli
lower
anim
sampl
day
earli
peak
viral
replic
seen
respiratori
tract
agm
also
report
mice
ferret
cat
martina
et
al
entir
clear
kinet
compar
human
report
viral
load
respiratori
secret
sar
patient
base
sampl
subject
treat
steroid
ribavirin
agm
support
replic
sarscov
associ
evid
pneumon
least
day
viral
infect
pneumon
patchi
consist
correspond
find
experiment
infect
mice
hamster
robert
et
al
press
subbarao
et
al
animaltoanim
variabl
rapid
clearanc
viru
lung
rapid
resolut
pneumon
agm
consider
preclud
speci
ideal
model
evalu
efficaci
vaccin
viral
challeng
dr
l
j
anderson
g
ksiazek
center
diseas
control
prevent
cdc
atlanta
ga
kindli
provid
sarscov
urbani
strain
use
studi
ksiazek
et
al
viru
isol
passag
twice
vero
cell
cdc
passag
twice
vero
cell
laboratori
vero
cell
maintain
optipro
sfm
invitrogen
carlsbad
ca
vitro
manipul
infecti
viru
perform
insid
biosafeti
cabinet
biosafeti
contain
level
facil
personnel
wore
power
air
purifi
respir
hepa
airmat
saint
paul
mn
previous
describ
viru
titer
secret
tissu
determin
vero
cell
monolay
previous
describ
express
tcid
ml
tcid
g
lower
limit
detect
tcid
ml
tcid
g
respect
nih
anim
care
use
committe
approv
monkey
studi
carri
anim
biosafeti
level
facil
personnel
enter
facil
wore
power
airpurifi
respir
hepa
airmat
saint
paul
mn
four
juvenil
african
green
monkey
cercopithecu
atheiop
chlorocebu
sabeu
four
rhesu
monkey
macaca
mulata
four
cynomolgu
monkey
macaca
fasiculari
inocul
intranas
intratrach
ml
tcid
sarscov
site
nt
sampl
upper
respiratori
tract
collect
daili
day
prior
inocul
day
day
postinocul
tl
sampl
lower
respiratori
tract
collect
day
plasma
urin
sampl
collect
day
postinocul
duplic
sampl
flash
frozen
store
sampl
avail
viru
titrat
nt
tl
plasma
urin
fecal
sampl
assay
presenc
infecti
sarscov
piperacillin
sigma
aldrich
co
st
loui
mo
gentamicin
invitrogen
grand
island
ny
amphotericin
b
qualiti
biolog
gaithersburg
md
ad
tissu
cultur
medium
final
concentr
mgl
respect
determin
viru
titer
monkey
sampl
monkey
observ
daili
sign
clinic
ill
day
day
day
postinocul
rectal
temperatur
monkey
record
blood
collect
day
complet
blood
count
alanin
amino
transferas
alt
isocitr
dehydrogenas
icd
gamma
glutamyl
transferas
ggt
level
determin
whether
primari
infect
protect
monkey
subsequ
challeng
agm
inocul
intranas
intratrach
tcid
sarscov
month
end
primari
infect
studi
nt
tl
collect
titer
describ
primari
infect
rhesu
cynomolgu
monkey
euthan
month
primari
infect
agm
euthan
month
follow
challeng
infect
tissu
sampl
obtain
liver
spleen
kidney
lung
viru
isol
addit
studi
undertaken
agm
order
determin
whether
replic
sarscov
associ
histopatholog
chang
lung
compar
level
viru
replic
lung
tissu
seen
nt
swab
tl
fluid
four
agm
inocul
intranas
intratrach
tcid
sarscov
two
mock
infect
leibovitz
medium
invitrogen
day
two
day
later
two
sarscov
infect
one
mockinfect
agm
euthan
remain
two
sarscov
infect
one
mockinfect
agm
euthan
day
four
monkey
observ
daili
sign
clinic
ill
rectal
temperatur
record
blood
collect
day
complet
blood
count
determin
level
liver
enzym
nt
swab
collect
daili
tl
fluid
collect
everi
day
till
anim
euthan
necropsi
trachea
nasal
turbin
tissu
block
cm
hilar
peripher
region
lobe
lung
frozen
assay
viru
titrat
similar
lung
tissu
block
fix
glutaraldehyd
electron
microscopi
remain
tissu
place
formalin
histopatholog
examin
addit
tissu
sampl
collect
histopatholog
examin
includ
liver
spleen
kidney
heart
bone
marrow
intestin
fecal
sampl
agm
cynomolgu
monkey
thaw
g
fece
suspend
steril
phosphat
buffer
salin
final
wv
solut
rna
extract
per
manufactur
protocol
qiagen
viral
rna
kit
valencia
ca
clarifi
supernat
store
fecal
sampl
rhesu
monkey
test
revers
transcript
realtim
pcr
analysi
perform
use
stratagen
brilliant
plu
twostep
quantit
rtpcr
core
reagent
kit
per
manufactur
protocol
thermocycl
stratagen
lajolla
ca
primer
taqman
probe
synthes
qiagen
use
amplifi
detect
small
fragment
locat
sar
cov
norf
access
number
sequenc
primer
use
follow
forward
aag
agc
tac
ccg
revers
gta
cca
tct
ggg
gct
probe
hexctc
ttt
cat
ttt
gcc
gtc
acc
acc
sampl
fragment
consist
amplifi
two
independ
assay
perform
duplic
triplic
report
posit
detect
sarscov
viral
rna
serum
sampl
assay
presenc
neutral
antibodi
microneutr
assay
start
dilut
serum
dilut
complet
neutral
infect
tcid
viru
calcul
method
reed
muench
describ
previous
serum
sampl
neutral
viru
infect
start
dilut
assign
titer
determin
fourfold
rise
titer
serial
fourfold
dilut
heattreat
sera
assay
presenc
igg
antibodi
spike
protein
sarscov
elisa
assay
serum
dilut
begin
appli
well
immulon
plate
dynex
technolog
inc
chantilli
va
coat
ng
per
well
purifi
recombin
baculovirusexpress
sar
protein
protein
scienc
inc
meridian
ct
second
antibodi
use
rabbit
antimonkey
igg
dilut
icn
aurora
oh
elisa
develop
use
alkalin
phosphataselabel
goat
antirabbit
antibodi
icn
follow
substrat
elisa
antibodi
titer
record
serum
dilut
optic
densiti
read
nm
exceed
exceed
read
well
coat
antigen
twofold
colorimetr
immunoalkalin
phosphatas
ihc
method
use
previous
describ
doublestain
ihc
perform
use
peroxidas
polym
dakocytom
inc
carpinteria
ca
label
antibodi
cytokeratin
surfact
follow
mous
antisarscov
antibodi
label
immunoalkalin
phosphatas
polym
log
transform
viru
titer
compar
twotail
test
statist
signific
assign
differ
p
valu
